RBCC: New Research Could Massively Expand Market For Addiction Therapy Technology
6/26/2014 10:49:03 AM
MIRAMAR BEACH, Fla.--(BUSINESS WIRE)--As Rainbow Coral Corp. (OTCBB: RBCC) works to deliver a new injectable, sustained-release technology poised to vastly improve patients' use of Naltrexone, new research into the drug’s potential could soon dramatically expand the drug’s market and usage. Naltrexone has been approved by the FDA for use in combatting alcohol and heroin addiction by fine-tuning the brain’s chemical rewards system to help reduce cravings. But new research into the drug’s properties has revealed promising applications for the treatment of autoimmune diseases and chronic pain.
Help employers find you! Check out all the jobs and post your resume.
comments powered by